81 results
Page 2 of 5
8-K
EX-10.1
50gpy3mwk4ku7
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.3
z7db3f1dy2qvqec
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.2
fnztapd i5i5yor
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
j4l7dhl2ok zxcbzaf
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-10.2
557v 3xex3oyq
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-10.1
6g3h9scyob isole
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-10.1
s2l6 zic46
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
rv0l8
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
bd6 uajfe5i8
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
t050fqaup9
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.2
5ivifp 4ia3ssori7hyw
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.2
u04hac8
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-10.1
7q79o0g sx
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-10.1
ja7qo
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am